Net Income (Loss) Attributable to Parent in USD of Mosaic ImmunoEngineering Inc. from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mosaic ImmunoEngineering Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2010 to Q3 2025.
  • Mosaic ImmunoEngineering Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$165,361.000, a 11.4% increase year-over-year.
  • Mosaic ImmunoEngineering Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$671,753.000, a 36.9% increase year-over-year.
  • Mosaic ImmunoEngineering Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$921,983.000, a 8.56% increase from 2023.
  • Mosaic ImmunoEngineering Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1,008,235.000, a 57.7% increase from 2022.
  • Mosaic ImmunoEngineering Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2,380,870.000, a 35.4% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Mosaic ImmunoEngineering Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$671,753 -$165,361 +$21,369 +11.4% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 -$693,122 -$172,028 +$121,689 +41.4% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025
Q1 2025 -$814,811 -$181,320 +$107,172 +37.1% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025
Q4 2024 -$921,983 -$153,044 +$142,514 +48.2% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$1,064,497 -$186,730 +$146,516 +44% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025
Q2 2024 -$1,211,013 -$293,717 -$313,329 -16% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025
Q1 2024 -$897,684 -$288,492 +$110,551 +27.7% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025
Q4 2023 -$1,008,235 -$295,558 +$238,544 +44.7% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$1,246,779 -$333,246 -$179,594 -1.2% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024
Q2 2023 -$1,067,185 $19,612 +$949,244 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$2,016,429 -$399,043 +$364,441 +47.7% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$2,380,870 -$534,102 +$316,166 +37.2% 01 Oct 2022 31 Dec 2022 10-K 15 Apr 2024
Q3 2022 -$2,697,036 -$153,652 +$894,291 +85.3% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 -$3,591,327 -$929,632 +$49,792 +5.1% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 -$3,641,119 -$763,484 +$43,359 +5.4% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$3,684,478 -$850,268 -$219,225 -34.7% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 -$3,465,253 -$1,047,943 -$661,418 -1.7% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 -$2,803,835 -$979,424 -$979,384 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 -$1,824,451 -$806,843 -$335,843 -71.3% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$1,488,608 -$631,043 -$117,939 -23% 01 Sep 2020 30 Nov 2020 10-Q 29 Dec 2020
Q3 2020 -$1,370,669 -$386,525 -$43,267 -12.6% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q2 2020 -$1,327,402 -$40* +$249,305 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 -$471,000 -$286,922 -1.6% 30 Mar 2020 31 Mar 2020 10-Q 05 May 2021
Q1 2020 -$1,576,707 -$101,280 +$82,798 +45% 01 Dec 2019 29 Feb 2020 10-Q 08 Apr 2020
Q4 2019 -$1,289,785 -$513,104 -$360,982 -2.4% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2020
Q3 2019 -$928,803 -$343,258 -$130,340 -61.2% 01 Jun 2019 31 Aug 2019 10-Q 11 Oct 2019
Q2 2019 -$798,463 -$249,345 +$59,990 +19.4% 01 Mar 2019 31 May 2019 10-K 24 Aug 2020
Q1 2019 -$858,453 -$184,078 +$72,335 +28.2% 01 Dec 2018 28 Feb 2019 10-Q 08 Apr 2020
Q4 2018 -$930,788 -$152,122 +$198,914 +56.7% 01 Sep 2018 30 Nov 2018 10-Q 14 Jan 2020
Q3 2018 -$1,129,702 -$212,918 +$79,748 +27.2% 01 Jun 2018 31 Aug 2018 10-Q 11 Oct 2019
Q2 2018 -$1,209,450 -$309,335 +$18,066 +5.5% 01 Mar 2018 31 May 2018 10-K 29 Aug 2019
Q1 2018 -$1,227,516 -$256,413 +$52,910 +17.1% 01 Dec 2017 28 Feb 2018 10-Q 15 Apr 2019
Q4 2017 -$1,280,426 -$351,036 -$1,318,060 -1.4% 01 Sep 2017 30 Nov 2017 10-Q 15 Apr 2019
Q3 2017 $37,634 -$292,666 +$83,002 +22.1% 01 Jun 2017 31 Aug 2017 10-Q 15 Apr 2019
Q2 2017 -$45,368 -$327,401 +$245,684 +42.9% 01 Mar 2017 31 May 2017 10-K 29 Aug 2018
Q1 2017 -$291,052 -$309,323 +$222,542 +41.8% 01 Dec 2016 28 Feb 2017 10-Q 16 Apr 2018
Q4 2016 -$513,594 $967,024 +$1,053,443 01 Sep 2016 30 Nov 2016 10-Q 16 Jan 2018
Q3 2016 -$1,567,037 -$375,668 -$300,437 -4% 01 Jun 2016 31 Aug 2016 10-Q 16 Oct 2017
Q2 2016 -$1,266,600 -$573,085 -$37,894 -7.1% 01 Mar 2016 31 May 2016 10-K 29 Aug 2017
Q1 2016 -$1,228,706 -$531,865 -$557,147 -22% 01 Dec 2015 29 Feb 2016 10-Q 13 Apr 2017
Q4 2015 -$671,559 -$86,419 +$347,747 +80.1% 01 Sep 2015 30 Nov 2015 10-Q 17 Jan 2017
Q3 2015 -$1,019,306 -$75,231 +$518,722 +87.3% 01 Jun 2015 31 Aug 2015 10-Q 17 Oct 2016
Q2 2015 -$1,538,028 -$535,191 +$116,028 +17.8% 01 Mar 2015 31 May 2015 10-K 29 Aug 2016
Q1 2015 -$1,654,056 $25,282 +$421,292 01 Dec 2014 28 Feb 2015 10-Q 14 Apr 2016
Q4 2014 -$2,075,348 -$434,166 -$501,418 -7.5% 01 Sep 2014 30 Nov 2014 10-Q 14 Jan 2016
Q3 2014 -$1,573,930 -$593,953 -$107,063 -22% 01 Jun 2014 31 Aug 2014 10-Q 15 Oct 2015
Q2 2014 -$1,466,867 -$651,219 -$2,358,872 -1.4% 01 Mar 2014 31 May 2014 10-K 31 Aug 2015
Q1 2014 $892,005 -$396,010 +$515,711 +56.6% 01 Dec 2013 28 Feb 2014 10-Q 14 Apr 2015
Q4 2013 $376,294 $67,252 -$1,125,443 -94.4% 01 Sep 2013 30 Nov 2013 10-Q 14 Jan 2015
Q3 2013 $1,501,737 -$486,890 +$405,522 +45.4% 01 Jun 2013 31 Aug 2013 10-Q 15 Oct 2014
Q2 2013 $1,096,215 $1,707,653 +$3,213,482 01 Mar 2013 31 May 2013 10-K 19 Aug 2014
Q1 2013 -$2,117,267 -$911,721 +$334,404 +26.8% 01 Dec 2012 28 Feb 2013 10-Q 14 Apr 2014
Q4 2012 -$2,451,671 $1,192,695 +$2,197,177 01 Sep 2012 30 Nov 2012 10-Q 14 Jan 2014
Q3 2012 -$4,648,848 -$892,412 +$171,557 +16.1% 01 Jun 2012 31 Aug 2012 10-Q 15 Oct 2013
Q2 2012 -$4,820,405 -$1,505,829 +$860,623 +36.4% 01 Mar 2012 31 May 2012 10-K 23 Aug 2013
Q1 2012 -$5,681,028 -$1,246,125 +$4,402,884 +77.9% 01 Dec 2011 29 Feb 2012 10-Q 15 Apr 2013
Q4 2011 -$10,083,912 -$1,004,482 +$495,048 +33% 01 Sep 2011 30 Nov 2011 10-Q 14 Jan 2013
Q3 2011 -$10,578,960 -$1,063,969 +$936,430 +46.8% 01 Jun 2011 31 Aug 2011 10-Q 15 Oct 2012
Q2 2011 -$11,515,390 -$2,366,452 01 Mar 2011 31 May 2011 10-K 29 Aug 2012
Q1 2011 -$5,649,009 01 Dec 2010 28 Feb 2011 10-Q 16 Apr 2012
Q4 2010 -$1,499,530 01 Sep 2010 30 Nov 2010 10-Q 17 Jan 2012
Q3 2010 -$2,000,399 01 Jun 2010 31 Aug 2010 10-Q 17 Oct 2011

Mosaic ImmunoEngineering Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$921,983 +$86,252 +8.6% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$1,008,235 +$1,372,635 +57.7% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$2,380,870 +$1,303,608 +35.4% 01 Jan 2022 31 Dec 2022 10-K 15 Apr 2024
2021 -$3,684,478 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2019 -$1,060,528 -$262,065 -32.8% 01 Jun 2019 31 May 2020 10-K 24 Aug 2020
2018 -$798,463 +$410,987 +34% 01 Jun 2018 31 May 2019 10-K 24 Aug 2020
2017 -$1,209,450 -$1,164,082 -25.7% 01 Jun 2017 31 May 2018 10-K 29 Aug 2019
2016 -$45,368 +$1,221,232 +96.4% 01 Jun 2016 31 May 2017 10-K 29 Aug 2018
2015 -$1,266,600 +$271,428 +17.6% 01 Jun 2015 31 May 2016 10-K 29 Aug 2017
2014 -$1,538,028 -$71,161 -4.9% 01 Jun 2014 31 May 2015 10-K 29 Aug 2016
2013 -$1,466,867 -$2,563,082 -2.3% 01 Jun 2013 31 May 2014 10-K 31 Aug 2015
2012 $1,096,215 +$5,916,620 01 Jun 2012 31 May 2013 10-K 19 Aug 2014
2011 -$4,820,405 +$6,694,985 +58.1% 01 Jun 2011 31 May 2012 10-K 23 Aug 2013
2010 -$11,515,390 01 Jun 2010 31 May 2011 10-K 29 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.